Although available elsewhere, bethanidine remains under study in the U.S. and its hemodynamic effects are unreported. Therefore, 29 patients with moderately severe essential hypertension received one of four oral dose levels (0.10, 0.25, 0.35, or 
nidine in patients with essential hypertension of moderately severe vascular disease.
Materials and Methods
Twenty-nine patients with essential hypertension of moderately severe vascular disease, who were evaluated completely to exclude secondary forms of hypertension and to assess involvement of target organs, were included in this study. All were informed about the nature of the investigation and signed consent forms approved by our institutional Human Experimentation Committee. These patients either had never received antihypertensive drugs prior to evaluation or had discontinued their medications at least four weeks prior to study. The hemodynamic studies were performed in the morning after an overnight fast without premedication in a quiet, well-lit room using previously reported techniques. 14 In brief, small segments of polyethylene tubing were introduced intravascularly through an antecubital vein and brachial artery up to the shoulder level using the Seldinger technique." This enabled continuous direct recording at normal (25 mm/sec) and rapid (100 mm/sec) paper speeds of arterial and venous pressures simultaneously with the electrocardiogram (lead II). Control (pretreatment) supine determinations (in triplicate) of cardiac output were obtained with 5 mg indocyanine dye followed by a 5 ml saline bolus flush injection; and this was repeated once again during the fifth minute of 50°upright tilt. After inscription of each indicator-dilution curve the withdrawn blood was returned to the patient. These curves were replotted semilogarithmically to calculate the minute cardiac output. Thus, these hemodynamic measurements permitted calculation of: cardiac index, by dividing cardiac output by body surface area; total peripheral resistance index, by dividing mean arterial pressure by cardiac index; and left ventricular ejection rate index, by dividing stroke index by the ejection time. All statistical data were calculated by paired data analysis using the Student's t-test.
The 29 patients were classified into four groups. Groups I, II, and III were composed of six, six, and three patients, respectively, and received 0.10, 0.25, and 0.35 mg/kg (body weight) bethanidine in single oral doses, respectively. Supine and upright hemodynamic studies were obtained before and one, one and one-half, two, and three hours after administration of the drug. Group IV (14 patients, all men) received a 0.50 mg/kg oral dose; and hemodynamic measurements were obtained before and one, two, and three hours after administration of bethanidine. All of these latter patients had hypertensive retinopathy of grades II Thus, the reflexive sympathetic adjustments were significantly modified by bethanidine, so that the reflexive increase in total peripheral vascular resistance was significantly reduced (19 to 6%, P < 0.025) and the increase in diastolic pressure during the overshoot phase of the Valsalva maneuver was attenuated (from 42 to 10%, P < 0.001; fig. 3 ).
Arterial pressure was continuously monitornd for one hour after oral administration of bethanidine and no significant changes were observed, thereby providing no evidence to 
